The parathyroid glands normally produce a substance called parathyroid hormone ( PTH). PTH plays a critical role in the regulation and metabolism of calcium within the body. Normally this is under tight regulation from various feedback mechanisms within the body.
When the Parathyroid glands do not function correctly it is mostly associated with disorders related to either overactive or underactive gland secretions.
There are four ‘pea sized’ lobes or glands that are located usually immediately behind the thyroid in your neck adjacent the Trachea (windpipe). ‘Para’ means ‘near’, which explains the name.
While the Parathyroid glands are part of the body's endocrine system, the thyroid and parathyroid glands are completely different. The endocrine system consists of a range of glands that secrete hormones into the bloodstream.
The main parathyroid hormone (PTH) is a chemical that regulates the amount of calcium, phosphorus and magnesium in the bones and blood.
The minerals calcium and phosphorus are crucial for healthy bones. Blood-borne calcium is also needed for the proper functioning of muscle and nerve cells.
Every cell and organ in the body uses calcium as a signal to regulate their normal function. Therefore, it is crucial that calcium levels are tightly controlled.
Causing abnormally high blood calcium levels (hypercalcaemia) occurs when the Parathyroid gland releases extra PTH, mainly "stealing" calcium from the bone.
This condition can lead to:
In severe elevations of blood calcium levels called "hypercalcemic crisis," a patient can become comatose or near-comatose due to organ failure.
Hypoparathyroidism is characterised by low levels of PTH, this causes glands to drop hormone production, which decreases the amount of calcium in the blood. This then affects nerve and muscle cells which are unable to function properly.
Hypoparathyroidism can cause:
Multiple endocrine neoplasias 1 (MEN1) is an inherited condition, characterised by tumours on at least two glands of the endocrine system.
MEN1 can involve tumours in the parathyroid glands and any other hormone producing organs including the pituitary, pancreas, adrenals and thyroid.
Parathyroid Disease commonly affects more women aged 50 years and over. The most common age to be diagnosed with Parathyroid disease is the early 60's with most sufferers between 40 and 75.
Patients in this group may also have heart problems related to the high calcium.
Other ages also get parathyroid disease, but in younger patients, it is typically due to a genetic/family disorder such as MEN-1 syndrome.
Hypocalcaemia can be caused by a lack of vitamin D
Multiple endocrine neoplasias 1 is a genetic disorder
These symptoms depend on which glands are affected.
Patients are diagnosed through routine blood testing or screening for osteoporosis and many patients have only vague, non-specific symptoms.
Diagnostic tests for hyperparathyroidism include:
Diagnostic tests for hyperparathyroidism include:
Diagnostic tests for Multiple Endocrine Neoplasia include:
If a diagnosis of any Parathyroid disease is made and is not treated it can have serious consequences for the patient’s health.
Depending on the condition untreated Parathyroid disease can lead to worsening symptoms, system failures and premature death.
Treatment varies depending on the combination of glands affected by tumours and their size etc. In the case they are operable or other non-invasive remedies are not suitable treatment can include:
Parathyroidectomy treatment is indicated for some patients with hyperparathyroidism (high levels of parathyroid hormone) as long term exposure to high blood calcium levels can cause significant health side effects. These include osteoporosis, bone fractures, kidney stones, stomach ulcers and depression.
Parathyroidectomy is a surgical procedure that involves the removal of one or more of the parathyroid glands (these glands produce a hormone that increases levels of calcium in the blood).
The type of surgery depends on the type of parathyroid problem and the results of imaging investigations pre-operatively.
Minimally invasive parathyroidectomy: for patients with a single abnormal parathyroid gland that has been identified on imaging this is the approach of choice. It allows exploration of one side of the neck through a smaller incision than is conventionally used.
Gland exploration is the traditional approach to parathyroid surgery that involves a larger incision to allow exploration of both sides of the neck. This is indicated in patients who have hyperparathyroidism without an abnormal gland identified on imaging. It is also used if there is co-existing thyroid disease, in patients with hyperparathyroidism due to renal failure and patients with hereditary parathyroid diseases.
The abnormal gland (tumour) is identified and removed carefully. Sometimes more than one abnormal gland is removed. If all four glands are removed, a part of one of the glands may be implanted in the forearm or the sternocleidomastoid muscle in the neck so that its function is not completely lost.
After removal of the tissue, the incisions are then closed with absorbable hidden sutures and waterproof glue.
CONDITIONS
CANCER SURGERY